The Centers for Medicare & Medicaid Services will assign specific C-codes for the Inspire V neurostimulation device in the April 2026 Integrated Outpatient Code Editor update, standardizing billing procedures and clarifying coding guidelines for hospitals and surgical centers.

Earlier in 2026, Inspire Medical Systems lowered its revenue guidance due to coding headwinds that created reimbursement uncertainties; the introduction of dedicated C-codes removes these obstacles by ensuring more predictable payments for the device.

Investors responded with a 19.7% share price increase, reflecting renewed confidence in long-term growth prospects. Analysts expect the regulatory win to accelerate device adoption, stabilize revenue streams and support future sales momentum.